Cancer Control (CC) The over-arching goal of the Cancer Control (CC) Program is to reduce cancer risk and mortality and to improve the quality of care and quality of life for individuals and populations. Program members conduct cancer behavioral research, addressing the adoption of cancer-causing behaviors by adolescents and young adults, and health services research, addressing the impact of emerging technologies and health care policies on cancer care and outcomes across the continuum from prevention to screening and treatment. Working together through inter-disciplinary teams that include physician-scientists, behavioral and communications scientists, functional brain scientists, psychologists, decision scientists, economists, statisticians, geospatial and health services researchers; 35 program members from 11 departments actively are pursuing six scientific themes: (1) Media and marketing influences on adoption of tobacco, alcohol and eating behaviors during adolescence; (2) Tobacco regulatory research, (3) Geospatial research addressing how local geography affects cancer behaviors and outcomes; (4) Comparative effectiveness of emerging cancer screening and treatment technologies; (5) Studies that characterize how practice variation and health care reform affect cancer care and outcomes; and (6) Effective communication of the benefits and harms of cancer screening and treatments, to foster informed choice and enhanced survivorship through decision support. Translational goals include establishing the scientific basis for regulatory policies, aimed at tobacco and other cancer causing behaviors, and for policies that guide cancer screening and the delivery of cancer care. Major program accomplishments include establishing a scientific basis for policies to limit movie smoking cues and translating those findings into policies that reduced exposure, publishing paradigm-shifting studies on overdiagnosis as it relates to cancer screening and diagnosis, conducting practice-changing clinical trials that affected recommendations for lung cancer screening and early palliative care, and delivering cancer care to the rural underserved. Program Co-Directors actively recruit scientists and foster a stimulating inter- disciplinary research environment through monthly research group meetings (behavior and health services), working group meetings (lung screening, decision support/survivorship), quarterly full program meetings, and active mentorship of Program members. NCCC further supports CC Program research through pilot funding and strategic recruitments of new investigators, including early-stage investigators who have strengthened CC ties with The Dartmouth Institute. Members heavily use the Biostatistics Shared Resource, which now includes geospatial services essential to our ongoing research. More than 470 cancer-related manuscripts have been published in the reporting period (17% in journals with an impact factor of 8 or more), with 32 members on intra-program (151=32%) and 21 members on inter-program (89=19%) collaborations. Total Program funding currently is $9.6M, of which $9.1M is peer-reviewed and $3.8M is from NCI.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA023108-40
Application #
9616827
Study Section
Subcommittee I - Career Development (NCI)
Project Start
Project End
Budget Start
2018-12-01
Budget End
2019-11-30
Support Year
40
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Dartmouth College
Department
Type
DUNS #
041027822
City
Hanover
State
NH
Country
United States
Zip Code
03755
Shee, Kevin; Jiang, Amanda; Varn, Frederick S et al. (2018) Cytokine sensitivity screening highlights BMP4 pathway signaling as a therapeutic opportunity in ER+ breast cancer. FASEB J :fj201801241R
Rodriguez-Garcia, Marta; Fortier, Jared M; Barr, Fiona D et al. (2018) Aging impacts CD103+ CD8+ T cell presence and induction by dendritic cells in the genital tract. Aging Cell 17:e12733
Shajani-Yi, Zahra; de Abreu, Francine B; Peterson, Jason D et al. (2018) Frequency of Somatic TP53 Mutations in Combination with Known Pathogenic Mutations in Colon Adenocarcinoma, Non-Small Cell Lung Carcinoma, and Gliomas as Identified by Next-Generation Sequencing. Neoplasia 20:256-262
Szczepiorkowski, Zbigniew M; Burnett, Christine A; Dumont, Larry J et al. (2018) Apheresis buffy coat collection without photoactivation has no effect on apoptosis, cell proliferation, and total viability of mononuclear cells collected using photopheresis systems. Transfusion 58:943-950
Bossé, Yohan; Amos, Christopher I (2018) A Decade of GWAS Results in Lung Cancer. Cancer Epidemiol Biomarkers Prev 27:363-379
Pande, Mala; Joon, Aron; Brewster, Abenaa M et al. (2018) Genetic susceptibility markers for a breast-colorectal cancer phenotype: Exploratory results from genome-wide association studies. PLoS One 13:e0196245
Smith, T Jarrod; Sondermann, Holger; O'Toole, George A (2018) Co-opting the Lap System of Pseudomonas fluorescens To Reversibly Customize Bacterial Cell Surfaces. ACS Synth Biol 7:2612-2617
Gorlova, Olga Y; Li, Yafang; Gorlov, Ivan et al. (2018) Gene-level association analysis of systemic sclerosis: A comparison of African-Americans and White populations. PLoS One 13:e0189498
Schmit, Stephanie L; Edlund, Christopher K; Schumacher, Fredrick R et al. (2018) Novel Common Genetic Susceptibility Loci for Colorectal Cancer. J Natl Cancer Inst :
Cai, Yunliang; Wu, Shaoju; Zhao, Wei et al. (2018) Concussion classification via deep learning using whole-brain white matter fiber strains. PLoS One 13:e0197992

Showing the most recent 10 out of 1911 publications